loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

List of Drug Master Files (DMF) of Ilginatinib Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NS Pharma (1)

filter

01 NS-018 ACTIVE DRUG SUBSTANCE (1)

filter

01 U.S.A (1)

filter

01 Inactive (1)

filter

01 Blank (1)

URL Supplier Web Content
25731
Inactive
2012-01-25
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1526932-96-6 / Ilginatinib API manufacturers, exporters & distributors?

Ilginatinib manufacturers, exporters & distributors 1

31

PharmaCompass offers a list of Ilginatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ilginatinib manufacturer or Ilginatinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ilginatinib manufacturer or Ilginatinib supplier.

PharmaCompass also assists you with knowing the Ilginatinib API Price utilized in the formulation of products. Ilginatinib API Price is not always fixed or binding as the Ilginatinib Price is obtained through a variety of data sources. The Ilginatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ilginatinib

Synonyms

Ns-018, 1239358-86-1, 56r994wx4l, 6-n-[(1s)-1-(4-fluorophenyl)ethyl]-4-(1-methylpyrazol-4-yl)-2-n-pyrazin-2-ylpyridine-2,6-diamine, (s)-n-(1-(4-fluorophenyl)ethyl)-4-(1-methyl-1h-pyrazol-4-yl)-n'-(pyrazin-2-yl)pyridine-2,6-diamine, 2,6-pyridinediamine, n2-((1s)-1-(4-fluorophenyl)ethyl)-4-(1-methyl-1h-pyrazol-4-yl)-n6-2-pyrazinyl-

Cas Number

1526932-96-6

Unique Ingredient Identifier (UNII)

56R994WX4L

About Ilginatinib

Ilginatinib is an orally bioavailable, small molecule inhibitor of Janus-associated kinase 2 (JAK2) and Src-family kinases, with potential antineoplastic activity. Ilginatinib competes with ATP for binding to JAK2 as well as the mutated form JAK2V617F, thereby inhibiting the activation of JAK2 and downstream molecules in the JAK2/STAT3 (signal transducer and activator of transcription 3) signaling pathway that plays an important role in normal development, particularly hematopoiesis. In addition, ilginatinib inhibits the Src family tyrosine kinases. This eventually leads to the induction of tumor cell apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders (MPDs); JAK2V617F is a constitutively activated kinase that activates the JAK/STAT signaling pathway and dysregulates cell growth and function, and its expression transforms hematopoietic cells to cytokine-independent growth.

Ilginatinib Manufacturers

A Ilginatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ilginatinib, including repackagers and relabelers. The FDA regulates Ilginatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ilginatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Ilginatinib Suppliers

A Ilginatinib supplier is an individual or a company that provides Ilginatinib active pharmaceutical ingredient (API) or Ilginatinib finished formulations upon request. The Ilginatinib suppliers may include Ilginatinib API manufacturers, exporters, distributors and traders.

click here to find a list of Ilginatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ilginatinib USDMF

A Ilginatinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Ilginatinib active pharmaceutical ingredient (API) in detail. Different forms of Ilginatinib DMFs exist exist since differing nations have different regulations, such as Ilginatinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ilginatinib DMF submitted to regulatory agencies in the US is known as a USDMF. Ilginatinib USDMF includes data on Ilginatinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ilginatinib USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ilginatinib suppliers with USDMF on PharmaCompass.

Ilginatinib Manufacturers | Traders | Suppliers

Ilginatinib Manufacturers, Traders, Suppliers 1
99

We have 1 companies offering Ilginatinib

Get in contact with the supplier of your choice:

  1. NS Pharma
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY